Smith & Nephew ULTRATAPE is a non-absorbable, sterile, synthetic surgical suture composed of UHMW (Ultra High Molecular Weight) polyethylene, offered braided, in both blue and a co-braid of blue/ white. ULTRATAPE is flat in shape, and has a width of 2mm, meeting USP tensile strength requirement for size #2 surgical suture. ULTRATAPE does not comply with USP size classifications. When used with various anchoring implants in orthopedic procedures, it secures and holds the reattached tendon to bone.

AI/ML Overview

Here's a summary of the acceptance criteria and study information for the Smith & Nephew ULTRATAPE surgical suture, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance:

Acceptance Criteria	Reported Device Performance
Knot Tensile Strength met according to USP standard for non-absorbable, #2 size surgical suture.	"Mechanical testing data for Knot Tensile Strength according to USP standard for nonabsorbable, #2 size surgical suture demonstrates the device has met the performance specifications"

2. Sample Size Used for the Test Set and Data Provenance:

The document does not explicitly state the numerical sample size for the mechanical testing. However, it indicates that the testing was conducted "in accordance with USP requirements," which would imply a scientifically sound and sufficient sample for demonstrating compliance.

Sample size for test set: Not explicitly stated (implied by "in accordance with USP requirements").
Data provenance: Not explicitly stated (likely laboratory testing conducted by the manufacturer as part of the 510(k) submission process).

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications:

This information is not applicable to the type of device and study presented. The study involves mechanical testing against a recognized standard (USP), not expert interpretation of data.

4. Adjudication Method for the Test Set:

Not applicable. This was a mechanical test against a technical standard, not a study requiring expert adjudication.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, and its effect size:

No, an MRMC comparative effectiveness study was not done. This device is a surgical suture, and its performance is evaluated through mechanical testing, not by human readers interpreting images or data.

6. If a Standalone (algorithm only without human-in-the-loop) performance study was done:

Not applicable. This device is a physical medical device (suture), not an algorithm or AI system. Its performance is inherent to its physical properties, not a standalone algorithm.

7. The Type of Ground Truth Used:

The "ground truth" for this study was the USP standard for Knot Tensile Strength for non-absorbable, #2 size surgical suture. The device's performance was compared directly against this established technical specification.

8. The Sample Size for the Training Set:

Not applicable. There is no AI or machine learning component to this device, so there is no concept of a "training set."

9. How the Ground Truth for the Training Set Was Established:

Not applicable, as there is no training set for this device.

Summary

{0}------------------------------------------------

K132357

OCT 3 0 2013

Endoscopy Smith & Nephew, Inc. 150 Minuteman Road Andover, MA 01810 USA

T 978 749 1000 F 978 749 1443 www.smith-nephew.com

> We are smith&nephew

510(k) Summary

Date Prepared: October 21, 2013

Submitter Information	Contact Information
Smith & Nephew, Inc.150 Minuteman RoadAndover, MA 01810	Melody BiSenior Regulatory Affairs SpecialistPhone: (508) 337-4035Fax: (978) 749-1443

Device Name (Unmodified)
Trade or proprietary name	Smith & Nephew ULTRATAPE
Common or usual name	Non-absorbable Surgical Suture
Classification name	Polyethylene Non-absorbable Surgical Suture

Legally Marketed Predicate Device

The Smith & Nephew ULTRATAPE surgical suture is substantially equivalent in intended use and Fundamental Scientific Technology to the following legally marketed devices in commercial distribution:

K101377 Smith & Nephew ULTRABRAID II Suture (Cleared on April 8, 2011)

K041216 Smith & Nephew ULTRABRAID Suture (Cleared on June 7, 2004)

Device Description

Intended Use

Smith & Nephew ULTRATAPE is indicated for use in approximation and/or ligation of soft tissues, including allograft tissue for orthopedic surgeries.

{1}------------------------------------------------

Technological Characteristics

Smith & Nephew ULTRATAPE is substantially equivalent to its predicate devices, ULTRABRAID suture (K041216) and ULTRABRAID II suture (K101377) based on the same intended use, and the following commonalities in technological characteristics:

. Same UHMWPE material is used in the manufacture of proposed and predicate devices.
Both proposed and predicates have braided configurations. .
. The test method used to confirm the performance specifications of Knot Tensile Strength for both the proposed and predicate devices were conducted in accordance with USP requirements.

The differences between ULTRATAPE and its predicate devices include that ULTRATAPE has a different braiding configuration, which provides a flat, 2mm wide suture. ULTRATAPE does not comply with USP size classifications. These differences do not raise new questions of safety or efficacy. Therefore, ULTRATAPE is as safe and effective as its currently marketed predicate devices.

Performance Data

Mechanical testing data for Knot Tensile Strength according to USP standard for nonabsorbable, #2 size surgical suture demonstrates the device has met the performance specifications and therefore, is substantially equivalent to the currently marketed predicate devices,

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized design of three curved lines, resembling an abstract representation of the human form or a symbol of interconnectedness. The logo is black and white.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

October 30, 2013

Smith & Nephew Incorporated Ms. Melody Bi Senior Regulatory Affairs Specialist 150 Minuteman Road Andover, Massachusetts 01810

Re: K132357

Trade/Device Name: Smith & Nephew ULTRATAPE Regulation Number: 21 CFR 878.5000 Regulation Name: Nonabsorbable poly (ethylene terephthalate) surgical suture Regulatory Class: Class II Product Code: GAT Dated: September 25, 2013 Received: October 2, 2013

Dear Ms. Bi:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{3}------------------------------------------------

Page 2 - Ms. Melody Bi

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Mark N. Melkerson -S

Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: December 31, 2013 See PRA Statement on last page.

510(k) Number (if known) K132357

Device Name Smith & Nephew ULTRATAPE

Indications for Use (Describe)

Smith & Nephew ULTRATAPE is indicated for use in approximation and/or ligation of soft tissues, including allograft tissue for orthopedic surgeries.

Type of Use (Select one or both, as applicable)

[ Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

Regulation Number and Section

§ 878.5000 Nonabsorbable poly(ethylene terephthalate) surgical suture.

(a)
Identification. Nonabsorbable poly(ethylene terephthalate) surgical suture is a multifilament, nonabsorbable, sterile, flexible thread prepared from fibers of high molecular weight, long-chain, linear polyesters having recurrent aromatic rings as an integral component and is indicated for use in soft tissue approximation. The poly(ethylene terephthalate) surgical suture meets U.S.P. requirements as described in the U.S.P. Monograph for Nonabsorbable Surgical Sutures; it may be provided uncoated or coated; and it may be undyed or dyed with an appropriate FDA listed color additive. Also, the suture may be provided with or without a standard needle attached.(b)
Classification. Class II (special controls). The special control for this device is FDA's “Class II Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA.” See § 878.1(e) for the availability of this guidance document.